enGene Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $23.9M
Liabilities Breakdown FY2022
Total Liabilities: $47.4M
Asset Breakdown
Total Assets: $23.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $20.4M | 85.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $387.0K | 1.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $3.1M | 12.9% |
Liabilities Breakdown
Total Liabilities: $47.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $723.0K | 1.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $46.7M | 98.5% |